February 02, 2024
Cover Story
37
2
In the ATMP space, CGTs are hitting their stride with unprecedented approvals in the past year alone.
February 02, 2024
Peer-Review Research
37
2
The authors present a methodology to assess the contribution of individual filters to overall capacity of the direct filtration train, and elucidate how capacity is affected by characteristics of the cell culture broth and process parameters, including for enhanced upstream processes such as those incorporating high cell density perfusion.
February 02, 2024
Development
37
2
Despite slow growth over recent years, the CAR-T cell therapy space is expected to see considerable advancements in the near future.
February 02, 2024
Development
37
2
Buffers, stabilizers, and cryoprotectants play major roles in cell therapy formulations.
February 02, 2024
Upstream Processing
37
2
The milestone approval of a gene-edited therapeutic paves the way for gene-editing technologies.
February 02, 2024
Downstream Processing
37
2
SUS aids biopharma manufacturers to overcome the rigidity of more traditional stainless-steel technologies.
February 01, 2024
Manufacturing
37
2
Developing freeze-drying processes requires patience and deep product and process understanding.
February 01, 2024
Outsourcing
37
2
Strategizing a PK/PD study approach in early phase development facilitates a successful clinical progression.
February 01, 2024
From the CEO
37
2
Given its positioning at each new year’s commencement, the J.P. Morgan Healthcare conference helps establish the tone with which the pharmaceutical industry is viewed.
February 01, 2024
Ask The Expert
37
2
Validating computerized systems is required to demonstrate adherence to data integrity, says Susan J. Schniepp, distinguished fellow at Nelson Laboratories, LLC.